These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12650124)

  • 1. Program targets HIV+ injection drug users.
    AIDS Alert; 2002 Aug; 17(8):103-4. PubMed ID: 12650124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Needle exchange and the HIV outbreak among injection drug users in Vancouver, Canada.
    Wood E; Kerr T
    Subst Use Misuse; 2006; 41(6-7):841-3. PubMed ID: 16809174
    [No Abstract]   [Full Text] [Related]  

  • 3. Social support networks and medical service use among HIV-positive injection drug users: implications to intervention.
    Knowlton AR; Hua W; Latkin C
    AIDS Care; 2005 May; 17(4):479-92. PubMed ID: 16036234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Providers' HIV prevention discussions with HIV-seropositive injection drug users.
    Wilkinson JD; Zhao W; Santibanez S; Arnsten J; Knowlton A; Gómez CA; Metsch LR;
    AIDS Behav; 2006 Nov; 10(6):699-705. PubMed ID: 16639542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network models for HIV outreach and prevention programs for drug users.
    Trotter RT II; Bowen AM; Potter JM
    NIDA Res Monogr; 1995; 151():144-80. PubMed ID: 8742765
    [No Abstract]   [Full Text] [Related]  

  • 6. Urging others to be healthy: "intravention" by injection drug users as a community prevention goal.
    Friedman SR; Maslow C; Bolyard M; Sandoval M; Mateu-Gelabert P; Neaigus A
    AIDS Educ Prev; 2004 Jun; 16(3):250-63. PubMed ID: 15237054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development, description, and acceptability of a small-group, behavioral intervention to prevent HIV and hepatitis C virus infections among young adult injection drug users.
    Purcell DW; Garfein RS; Latka MH; Thiede H; Hudson S; Bonner S; Golub ET; Ouellet LJ;
    Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S73-80. PubMed ID: 17466465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'Social evils' and harm reduction: the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam.
    Hammett TM; Wu Z; Duc TT; Stephens D; Sullivan S; Liu W; Chen Y; Ngu D; Des Jarlais DC
    Addiction; 2008 Jan; 103(1):137-45. PubMed ID: 18028519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dialogue on the incapability/capability of injection drug users.
    Friedman SR; Mateu-Gelabert P; Sandoval M
    Subst Use Misuse; 2009; 44(13):1971-8. PubMed ID: 20001292
    [No Abstract]   [Full Text] [Related]  

  • 11. The care of injection-drug users with HIV infection.
    Newman RG
    N Engl J Med; 1994 Dec; 331(26):1773; author reply 1774. PubMed ID: 7984202
    [No Abstract]   [Full Text] [Related]  

  • 12. [Services for drug users. Making a difference in many lives].
    Medellín JM
    Sidahora; 2005; ():12-7. PubMed ID: 16634157
    [No Abstract]   [Full Text] [Related]  

  • 13. Baseline findings from the third collaborative injection drug users study/drug users intervention trial (CIDUS III/DUIT).
    Booth RE; Strathdee SA
    Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S1-3. PubMed ID: 17889451
    [No Abstract]   [Full Text] [Related]  

  • 14. Integrating HIV prevention into substance user treatment: current practices and challenges.
    Mitchell CG; Oltean A
    Subst Use Misuse; 2007; 42(14):2173-82. PubMed ID: 18097998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the prevalence of HIV-related behaviors and perceptions among 1832 injecting drug users in Sichuan, China.
    Lau JT; Zhang L; Zhang Y; Wang N; Lau M; Tsui HY; Zhang J; Cheng F
    Sex Transm Dis; 2008 Apr; 35(4):325-35. PubMed ID: 18277942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating care for hepatitis C virus (HCV) and primary care for HIV for injection drug users coinfected with HIV and HCV.
    Kresina TF; Bruce RD; Cargill VA; Cheever LW
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S83-8. PubMed ID: 16265621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [EUROVIHTA Project--specific intervention program for HIV infected patients to support the coping process with this chronic illness].
    Bock J; Escobar-Pinzon LC; Riemer D; Blanch J; Hautzinger M
    Psychother Psychosom Med Psychol; 2003 Jul; 53(7):310-8. PubMed ID: 12847665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV prevention for injecting drug users: the first 25 years and counting.
    Des Jarlais DC; Semaan S
    Psychosom Med; 2008 Jun; 70(5):606-11. PubMed ID: 18519886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Legal harm reduction among intravenous drug users.
    Kongsakon R; Pocham N
    J Med Assoc Thai; 2006 Sep; 89(9):1545-50. PubMed ID: 17100399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users.
    Margolin A; Avants SK; Warburton LA; Hawkins KA; Shi J
    Health Psychol; 2003 Mar; 22(2):223-8. PubMed ID: 12683743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.